Quantbot Technologies LP Boosts Position in Chemed Co. (NYSE:CHE)

Quantbot Technologies LP boosted its holdings in shares of Chemed Co. (NYSE:CHE) by 135.3% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 7,057 shares of the company’s stock after purchasing an additional 4,058 shares during the quarter. Quantbot Technologies LP’s holdings in Chemed were worth $3,829,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the business. EntryPoint Capital LLC raised its position in Chemed by 14.0% during the 1st quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock worth $94,000 after buying an additional 18 shares during the last quarter. Covestor Ltd raised its position in Chemed by 10.6% during the 1st quarter. Covestor Ltd now owns 219 shares of the company’s stock worth $141,000 after buying an additional 21 shares during the last quarter. Ballentine Partners LLC raised its position in Chemed by 3.4% during the 1st quarter. Ballentine Partners LLC now owns 660 shares of the company’s stock worth $424,000 after buying an additional 22 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Chemed by 34.4% during the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after purchasing an additional 22 shares during the period. Finally, Waterloo Capital L.P. grew its stake in shares of Chemed by 1.1% during the 4th quarter. Waterloo Capital L.P. now owns 2,252 shares of the company’s stock worth $1,317,000 after purchasing an additional 25 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Chemed news, EVP Nicholas Michael Westfall sold 2,000 shares of Chemed stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the sale, the executive vice president now owns 5,990 shares of the company’s stock, valued at approximately $3,363,864.20. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, Director Andrea R. Lindell sold 831 shares of Chemed stock in a transaction on Friday, August 16th. The stock was sold at an average price of $571.51, for a total transaction of $474,924.81. Following the transaction, the director now owns 5,725 shares in the company, valued at approximately $3,271,894.75. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Nicholas Michael Westfall sold 2,000 shares of Chemed stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total value of $1,123,160.00. Following the transaction, the executive vice president now owns 5,990 shares in the company, valued at approximately $3,363,864.20. The disclosure for this sale can be found here. Insiders have sold a total of 6,744 shares of company stock valued at $3,828,231 in the last 90 days. 3.32% of the stock is owned by insiders.

Chemed Price Performance

Shares of NYSE CHE opened at $578.99 on Tuesday. The stock has a market capitalization of $8.77 billion, a price-to-earnings ratio of 31.13, a PEG ratio of 2.31 and a beta of 0.44. Chemed Co. has a 12 month low of $497.36 and a 12 month high of $654.62. The firm’s 50 day simple moving average is $564.56 and its 200-day simple moving average is $578.95.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The firm had revenue of $595.88 million for the quarter, compared to analyst estimates of $599.20 million. During the same period in the previous year, the business earned $4.71 EPS. Chemed’s revenue for the quarter was up 7.6% compared to the same quarter last year. Analysts anticipate that Chemed Co. will post 21.77 earnings per share for the current fiscal year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were paid a $0.50 dividend. The ex-dividend date of this dividend was Monday, August 12th. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. This is a boost from Chemed’s previous quarterly dividend of $0.40. Chemed’s dividend payout ratio (DPR) is currently 10.76%.

Analyst Ratings Changes

Separately, Royal Bank of Canada dropped their price objective on shares of Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 21st.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.